Caffeine Sodium Benzoate from United States
> Caffeine Sodium Benzoate is a double salt combining caffeine with sodium benzoate, used in parenteral migraine treatments. Under Chapter Note 5(C)(1), salts of organic compounds are classified with the parent organic compound, so this product falls under tariff item 2939.30.00. It is supplied as a sterile powder for IV solutions.
Duty Rate — United States → Canada
0%
Import Tips
• > Provide a clear breakdown of the caffeine and sodium benzoate content on the commercial invoice
• Ensure the product is sterile and complies with Health Canada requirements for parenteral drugs
• Confirm the correct HS code to avoid reclassification